Press Releases

Microbialtec Utilized Two Methods to Achieve Pseudomonas Aeruginosa Genome Editin

ClinOne Closes Series A Funding Round to Scale its Site and Participant Engagement Platform, Data Driven Insights and Interoperability

The financing will advance ClinOne’s technology, accelerate growth, and drive expansion to serve clinical sites, participants, and families in clinical trials.

Crispr/Cas9 Platform Developed Maize Mutant Library Covering 800 Functional Genes with CRISPR/Cas9 Technology

Unlocking Faster Study Start with eProtocol Automation: Maximizing Efficiency in Clinical Trial Design

In recent years, eProtocol automation has emerged as a powerful tool for streamlining the protocol creation process, reducing errors, and improving efficiency.

Profacgen Released AP-MS Service for Protein Interaction Research

Creative BioMart Enhanced Its Bacterial Expression Service for Research Use

Peptidoglycan Structure Analysis Now Available at CD BioGlyco

Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Samsung Biologics Reports First Quarter 2023 Financial Results

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2023.

CD Formulation Enhances Its Food Ingredients Lineup with Upgraded Acidity Regulators, Anticaking Agents, and Coating Agents

Tower Cold Chain adds 2023 King's Award for Innovation to last year's Queen's Award

Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

Indica Labs and Lunit has announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products.

Meridian Medical Technologies, a Kindeva Drug Delivery Company, Investing $100+ Million in Bridgeton, Missouri, Expansion

Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility. Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.

MDClone Synthetic Data Platform Drives Deeper Provider/Life Sciences Collaboration for Therapeutic R&D

Unique platform enables providers to securely connect life science organizations to rich patient data to test hypotheses, develop clinical trials, and create life saving therapies

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency

CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis

CD Bioparticles has launched a range of reversed-phase chromatography resins with different monodisperse particle sizes.

STEMart Launches Bioburden and Sterility Testing for Medical Devices

STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities.

PEGylation technology

PEGylation is a revolutionary modification of a therapeutic protein, nucleic acid, or small drug molecule by covalently attaching polyethylene glycol (PEG) or a derivative thereof.

BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.